Megvii vs OrCam
Side-by-side on valuation, funding, investors, founders & more
Comparison updated: April 2026
Megvii is valued at $4B — more than 3x OrCam's N/A.
Head-to-Head Verdict
Megvii
3 wins
OrCam
1 win
Key Numbers
🇨🇳 China · Yin Qi
Valuation
$4B
Total Funding
$1.4B
1000+ employees
🇮🇱 Israel · Amnon Shashua
Valuation
N/A
Total Funding
$152M
100-500 employees
Both companies compete in the Computer Vision space, though from different geographies — Megvii in China and OrCam in Israel. Different stages (Private vs Series C) mean these companies face fundamentally different operational priorities.
Analyst Summary
Built from real data · Updated April 2026
Companies
Megvii and OrCam are direct competitors in Computer Vision. Megvii develops computer vision AI systems under its Face++ brand, producing facial recognition, human body analysis, and object detection technologies deployed in financial services authentication, smart city surveillance, retail analytics, and industrial quality control across China and international markets. OrCam develops AI wearable devices for people with visual impairments and reading difficulties, producing the OrCam MyEye, a small camera that clips to eyeglass frames and uses computer vision and text-to-speech AI to read text, identify faces, recognise products, and describe scenes aloud to the wearer in real time.
Funding & Valuation
Only Megvii has a public valuation on record ($4B); OrCam's has not been disclosed. On the funding front, Megvii has secured $1.4B, outpacing OrCam's $152M by $1.2B.
Growth Stage
OrCam was founded in 2010, 1 year before Megvii arrived in 2011. Growth stages differ: Megvii (Private) versus OrCam (Series C), a distinction that matters for both deal structure and competitive positioning. On headcount, Megvii reports 1000+ employees and OrCam reports 100-500.
Geography & Outlook
Geography separates them: Megvii in 🇨🇳 China and OrCam in 🇮🇱 Israel, each benefiting from local ecosystems. Awaira rates Megvii at 80 and OrCam at 65, a gap that reflects differences in capital efficiency and market traction. Under Yin Qi and Amnon Shashua respectively, both companies continue to chart aggressive growth paths.
Funding Velocity
Megvii
OrCam
Funding History
Megvii has completed 4 funding rounds, while OrCam has gone through 4. Megvii's most recent round was a Series D of $750M, compared to OrCam's Series C ($83.6M). Megvii is at Private while OrCam is at Series C — different points in their growth trajectory.
Team & Scale
Megvii is significantly larger with about 1000+ employees, compared to OrCam's 100-500. That's a 10x difference in headcount. They're close in age — Megvii started in 2011 and OrCam in 2010. Geographically, they're in different markets — Megvii operates out of China and OrCam from Israel.
Metrics Comparison
| Metric | Megvii | OrCam |
|---|---|---|
💰Valuation | $4B | N/A |
📈Total Funding | $1.4BWINS | $152M |
📅Founded | 2011WINS | 2010 |
🚀Stage | Private | Series C |
👥Employees | 1000+ | 100-500 |
🌍Country | China | Israel |
🏷️Category | Computer Vision | Computer Vision |
⭐Awaira Score | 80WINS | 65 |
Key Differences
Funding gap: Megvii has raised $1.2B more ($1.4B vs $152M)
Market experience: OrCam has 1 year more (founded 2010 vs 2011)
Growth stage: Megvii is at Private vs OrCam at Series C
Team size: Megvii has 1000+ employees vs OrCam's 100-500
Market base: 🇨🇳 Megvii (China) vs 🇮🇱 OrCam (Israel)
Direct competitors: Both operate in the Computer Vision market segment
Awaira Score: Megvii scores 80/100 vs OrCam's 65/100
Which Should You Choose?
Use these signals to make the right call
Choose Megvii if…
Top Pick- ✓Higher Awaira Score — 80/100 vs 65/100
- ✓More established by valuation ($4B)
- ✓Stronger investor backing — raised $1.4B
- ✓China-based for regional compliance or proximity
- ✓Megvii develops computer vision AI systems under its Face++ brand, producing facial recognition, human body analysis, and object detection technologies deployed in financial services authentication, smart city surveillance, retail analytics, and industrial quality control across China and international markets
Choose OrCam if…
- ✓More market experience — founded in 2010
- ✓Israel-based for regional compliance or proximity
- ✓OrCam develops AI wearable devices for people with visual impairments and reading difficulties, producing the OrCam MyEye, a small camera that clips to eyeglass frames and uses computer vision and text-to-speech AI to read text, identify faces, recognise products, and describe scenes aloud to the wearer in real time
Funding History
Megvii raised $1.4B across 4 rounds. OrCam raised $152M across 4 rounds.
Megvii
Series D
May 2019
Lead: Bank of China
Series C
Oct 2017
Lead: China State-Owned Capital Venture Investment Fund
Series B
Jul 2014
Lead: Qiming Venture Partners
Series A
Jun 2013
Lead: Sinovation Ventures
OrCam
Series C
Jun 2014
Series B
Feb 2013
Series A
Oct 2011
Seed
Jun 2010
Investor Comparison
No shared investors detected between these two companies.
Unique to Megvii
Users Also Compare
Explore Further
FAQ — Megvii vs OrCam
Is Megvii bigger than OrCam?▾
Which company raised more funding — Megvii or OrCam?▾
Which company has a higher Awaira Score?▾
Who founded Megvii vs OrCam?▾
What does Megvii do vs OrCam?▾
Which company was founded first?▾
Which company has more employees?▾
Are Megvii and OrCam competitors?▾
Bottom Line
Megvii edges ahead with an Awaira Score of 80, but OrCam (65) isn't far behind. The gap is narrow enough that it could shift with the next funding round.
Who Should You Watch?
Megvii has the edge right now — higher Awaira Score and more capital to work with. That said, OrCam could close the gap with the right round or product launch. Follow both profiles on Awaira to track funding rounds, team changes, and score updates.